Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -64.70% | 33.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -64.70% | 33.92% | |||
| Cost of Revenue | -49.19% | 17.35% | |||
| Gross Profit | -104.55% | 47.31% | |||
| SG&A Expenses | -40.34% | 64.43% | |||
| Depreciation & Amortization | -72.32% | -16.42% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -44.18% | 42.21% | |||
| Operating Income | 36.36% | -45.73% | |||
| Income Before Tax | 82.05% | -397.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 82.05% | -397.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 76.23% | -69.45% | |||
| EBIT | 36.36% | -45.73% | |||
| EBITDA | 36.47% | -49.88% | |||
| EPS Basic | 76.43% | -68.67% | |||
| Normalized Basic EPS | 81.90% | -404.35% | |||
| EPS Diluted | 79.50% | -67.71% | |||
| Normalized Diluted EPS | 83.62% | -404.35% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 10.34% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||